- 1 view
Συντονιστές
Presentations
T-CELL RECEPTOR AND IMMUNE-RESPONSE GENE STUDIES IN P. Batsaki TUMOR MICROENVI-RONMENT AND PERIPHERAL BLOOD IN HEAD AND NECK CANCER PATIENTS
THE TCR Vβ REPERTOIRE COMPOSITION AS A PREDICTIVE BIOMARKER OF IMMUNOTHERAPY EFFICIENCY IN NON-SMALL CELL LUNG CANCER PATIENTS
KMT2C IS A TUMOR SUPPRESSOR IN BLADDER CANCER AND ITS LOSS LEADS TO FAVORABLE RESPONSE TO IMMUNOTHERAPY
REAL-WORLD DATA ON IMMUNOTHERAPY IN PATIENTS WITH SOFT TISSUE SARCOMA: A STUDY FROM THE HELLENIC GROUP OF SARCOMA AND RARE CANCERS